Skip to main content

Afluria Quadrivalent News (Page 2)

Seqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older

CAMBRIDGE, Mass., Aug. 29, 2016 /PRNewswire/ – Seqirus announced today that the US Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in persons 18...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Influenza Prophylaxis

Afluria Quadrivalent patient information at Drugs.com